Serum prolactin (Prl) was measured following decapitation at various stages of the estrous cycle in control animals and following cervicovaginal stimulation with a glass rod. Serum Prl was low at 10.00 h at all stages of the estrous cycle but was elevated on the afternoon of proestrus with peak values at 16.00 h and on the afternoon of estrus with peak values at 13.00 h. Cervicovaginal stimulation resulted in 100% incidence of pseudopregnancy when performed on estrus and diestrus I and in a still high incidence when performed on proestrus. However, on diestrous day II, it caused only delayed pseudopregnancy in less than half the rats. Serum Prl was significantly elevated in the afternoon following stimulation on diestrous day I and on estrus, but the already elevated values on proestrus were not further augmented and there was no significant elevation on diestrous day II. Thus, there was a cyclic variation in the response of Prl to cervicovaginal stimulation which correlated with the incidence of immediate pseudopregnancy. Gonadal steroids at this stage of the cycle probably modulate the reflex release or Prl either by an action at the hypothalamic or pituitary level or at both sites. On the basis of evidence provided by others, the immediate release of Prl does not appear to be required for the induction of pseudopregnancy.

Keywords:
Prolactin, Cervical stimulation, Estrous cycle, Pseudopregnancy
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.